Novo Nordisk to restart Phase III haemophilia trials of concizumab
Novo Nordisk has collaborated with relevant authorities to determine a new approach for further development of concizumab. Credit: Novo Nordisk.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
